BIIO — Bionovate Technologies Income Statement
0.000.00%
Last trade - 00:00
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.19m
2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.005 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.001 | 0 | — | — | — |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.319 | 1.69 | 0.057 | 0.033 | 0.045 |
Operating Profit | -0.314 | -1.69 | -0.057 | -0.033 | -0.045 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.341 | -1.74 | -0.209 | -0.122 | -0.107 |
Net Income After Taxes | -0.341 | -1.74 | -0.209 | -0.122 | -0.107 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.323 | -1.74 | -0.209 | -0.122 | -0.107 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.323 | -1.74 | -0.209 | -0.122 | -0.107 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -38.3 | -2.7 | -1.34 | -0.005 | -0.002 |